<?xml version="1.0" encoding="UTF-8"?>
<ref id="B229">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Whitehead</surname>
    <given-names>S. S.</given-names>
   </name>
   <name>
    <surname>Durbin</surname>
    <given-names>A. P.</given-names>
   </name>
   <name>
    <surname>Pierce</surname>
    <given-names>K. K.</given-names>
   </name>
   <name>
    <surname>Elwood</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>McElvany</surname>
    <given-names>B. D.</given-names>
   </name>
   <name>
    <surname>Fraser</surname>
    <given-names>E. A.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2017</year>). 
  <article-title>In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination</article-title>. 
  <source>PLoS Negl. Trop. Dis.</source>
  <volume>11</volume>:
  <fpage>e0005584</fpage>. 
  <pub-id pub-id-type="doi">10.1371/journal.pntd.0005584</pub-id>
  <?supplied-pmid 28481883?>
  <pub-id pub-id-type="pmid">28481883</pub-id>
 </mixed-citation>
</ref>
